Literature DB >> 9210445

High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma.

M Dépôt1, S Leroux, G Caillé.   

Abstract

This paper describes a simple technique for extraction and a sensitive high-performance liquid chromatographic method for separation and quantitation of ondansetron in human plasma. The procedure involved liquid-liquid extraction of ondansetron from plasma, reversed-phase HPLC separation and ultraviolet detection at 305 nm. The internal standard method was applied for quantitation. The recovery of ondansetron was >85%. Linearity was good throughout the concentration range anticipated in human plasma from investigations in panic disorder (0.5-15 ng/ml, r2 ranging from 0.9953 to 0.9988). This method was applied to the determination of plasma concentrations of ondansetron in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210445     DOI: 10.1016/s0378-4347(97)00068-6

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.

Authors:  M Dépôt; S Merani; J Bradwejn; J Mukherjee; J Caillé; J Gutkowska; G Caillé
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

2.  Simultaneous quantification of ondansetron and tariquidar in rat and human plasma using a high performance liquid chromatography-ultraviolet method.

Authors:  Yae Eun Chong; Manting Chiang; Kiran Deshpande; Simon Haroutounian; Leonid Kagan; Jong Bong Lee
Journal:  Biomed Chromatogr       Date:  2019-09-01       Impact factor: 1.902

3.  Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans.

Authors:  Manting D Chiang; Karen Frey; Chris Lee; Evan D Kharasch; Dani Tallchief; Christopher Sawyer; Jane Blood; Hyunmoon Back; Leonid Kagan; Simon Haroutounian
Journal:  Br J Clin Pharmacol       Date:  2020-06-30       Impact factor: 4.335

4.  Experimentally designed electrochemical sensor for therapeutic drug monitoring of Ondansetron co-administered with chemotherapeutic drugs.

Authors:  Mona A Abdel Rahman; Shimaa A Atty; Sally S El-Mosallamy; Mohamed R Elghobashy; Hala E Zaazaa; Ahmed S Saad
Journal:  BMC Chem       Date:  2022-10-13

5.  Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System.

Authors:  Manting Chiang; Hyun-Moon Back; Jong Bong Lee; Sarah Oh; Tiffany Guo; Simone Girgis; Celine Park; Simon Haroutounian; Leonid Kagan
Journal:  Pharm Res       Date:  2020-09-28       Impact factor: 4.200

6.  A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form.

Authors:  P B Raval; Manisha Puranik; S J Wadher; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.